European Pharmaceutical Review

JUNE 24, 2022

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. Key areas of potential legislative change. Future outlook.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. The 2022 LSCIs don’t, however, include the speed and volume of NICE Technology Appraisals that were in previous iterations. The July 2022 LSCIs are the eighth version. The life sciences ecosystem.

Competition 59

Competition Medicine Patients Government 59

European Pharmaceutical Review

AUGUST 22, 2022

However, China and India are set to be fierce competition over the next decade, with 30 percent of respondents suggesting they would offshore >50 percent of clinical trials and operations to India, China or other lower-cost countries over the next five years.

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

MedCity News

JUNE 1, 2023

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. However, it’s a worthwhile endeavor not just for regulatory compliance but also for improving clinical outcomes and standing out in an increasingly competitive marketplace.

Patients 316

Patients Healthcare Healthcare Electronics 316

Pharma Pathway

SEPTEMBER 23, 2022

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance (Injectable) On 25th Sept’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 25th Sept’ 2022. Job Description.

Pharmaceutical 80

Pharmaceutical Competition Manufacturing Marketing 80

Pharma Pathway

DECEMBER 1, 2022

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance/ Engineering On 4th Dec’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 4th Dec’ 2022. Job Description. Mechanical.

Engineering 78

Engineering Pharmaceutical Competition Manufacturing 78

Pharma Marketing Network

DECEMBER 17, 2021

Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. While large corporations with mega campuses will start to “return to campus” in 2022, if they haven’t already, few are drawing hard lines around a full-time return. In this article, R.J.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Pharma Pathway

DECEMBER 14, 2022

Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022. Date : 17th Dec’ 2022. Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022. Job Description. Azico Biophore India Pvt. Hyderabad, India is fast emerging APIs manufacturing company. Time: 10:30 AM to 02:00 PM.

Manufacturing 80

Manufacturing Pharma Competition 80

Pharmaceutical Technology

JANUARY 25, 2023

It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.

Competition 59

Competition Sales Marketing Leads 59

pharmaphorum

JANUARY 19, 2023

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. GIRFT and competition He went on: “Improvement needs competition – everything else is a proxy; it doesn’t work well. When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.” Highly unlikely.”

Pharma 96

Pharma Competition Healthcare Healthcare 96

European Pharmaceutical Review

JANUARY 30, 2025

Julie Kim – Takeda’s future CEO Julie Kim has held the role of president of the US Business Unit and US country head since 2022 , taking over from Ramona Sequeira. I am excited to guide Takeda through the next phase, stated Kim. She has a part of the Takeda Executive Team since 2019.

Competition 59

Competition Marketing Management Leads 59

Pharmaceutical Technology

FEBRUARY 8, 2023

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. Pfizer maintained its third-place position in the market in 2022, reporting a market capitalization of $287.6

Marketing 78

Marketing Biopharma Sales Pharma 78

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 111

Marketing Medicine Competition Distribution 111

Spotio

JUNE 6, 2022

For example : SPOTIO’s Lead Machine gives reps and managers a competitive advantage because they are able to quickly build detailed customer profiles and map territories filled with qualified prospects in minutes. With so much potential, comes a lot of competition. The average person receives 147 emails every day!

Sales 111

Sales Prospecting B2B Sales Leads 111

Clarivate

DECEMBER 19, 2022

million lives, per Clarivate TM enrollment data as of January 2022. Under its CenterWell subsidiary Humana planned to operate 240-260 senior-only primary-care clinics by the end of 2022 while entering new markets such as Dallas-Fort Worth, Phoenix, Louisville, Nashville and Charlotte. million covered lives, ahead of No.

Competition 52

Competition Retail Insurance Marketing 52

European Pharmaceutical Review

JANUARY 16, 2023

According to 2022 data gathered by the World Health Organization (WHO), there are around 24 million schizophrenia patients. So, Rykindo ® will have to contend with the competition of other antipsychotic LAIs as treatments for psychosis disorders. Promising schizophrenia drug faces tough competition.

Food and Drug Administration 122

Food and Drug Administration FDA Competition Pharma 122

Clarify Health

FEBRUARY 20, 2024

Since July 2022, CMS has required most group health plans and issuers of group or individual health insurance to post price information for covered items and health services. For most, the concept of price transparency has been approached as a compliance necessity. However, it offers far more than just adherence to regulations.

Competition 52

Competition Marketing Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 11, 2024

As of September 2022, there were around 39 biosimilars approved and 22 marketed, the report stated. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. The latter of which is important in “gaining a competitive advantage”, the author noted. million by 2032, at 17.6

Marketing 105

Marketing Competition Manufacturing Medicine 105

European Pharmaceutical Review

DECEMBER 6, 2022

According to a market report by GlobalData, expanding generic drug competition and a drop in demand for COVID-19 vaccines and therapies have lowered the aggregate market capitalisation of the global top 20 biopharmaceutical companies by 9.1 trillion in Q2 2022 to $3.14 trillion in Q3 2022. percent from $3.45

Biopharma 96

Biopharma Marketing Food and Drug Administration Sales 96

Pharmaceutical Technology

JANUARY 30, 2023

According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022. According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022.

Sales 52

Sales Leads Competition Medicine 52

European Pharmaceutical Review

FEBRUARY 17, 2025

While this investment led to a seven percent rise in annual apprenticeship starts within the life sciences sector between 2018/19 and 2022/23, industry leaders have consistently argued that the narrow focus on apprenticeships left gaps in training provision. billion in 2017/18 to 2.5 billion in 2023/24.

Training 59

Training Pharmaceutical Government Manufacturing 59

European Pharmaceutical Review

OCTOBER 10, 2023

Unprecedented high payment rates in 2022 and 2023 have had a demonstrable impact on our ability to operate sustainably in the UK. AbbVie has always been a member of the Voluntary Scheme but left as a reflection of our view that the current scheme was broken.

Medicine 111

Medicine Pharma Government Competition 111

European Pharmaceutical Review

NOVEMBER 16, 2023

With procurement practices across Europe having a strong price focus, over time, this could impact the “sustainability of biosimilars and decrease competition, as well as reducing supply reliability”, the report acknowledged. “As Act4Biosimilars is supported by its founding sponsor, Sandoz.

Marketing 110

Marketing Education Competition Consulting 110

Pharmaceutical Technology

NOVEMBER 25, 2022

In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022.

Marketing 111

Marketing Patients Competition Manufacturing 111

World of DTC Marketing

JUNE 13, 2022

percent in 2022, even after taking cost-management initiatives into account, according to recent employer surveys. As an employer, providing health insurance to your employees can give your company a competitive edge, as it can enhance your employees’ overall satisfaction and productivity. And it’s expected to get worse.

Insurance 201

Insurance Healthcare Healthcare Consulting 201

European Pharmaceutical Review

JANUARY 9, 2023

Global M&A activity in 2022. The global life sciences mergers and acquisitions (M&A) investment totalled $105 billion in the first 11 months of 2022, with total deal value well down on 2021. EY’s research observed an overall drop in 2022 M&A investment worldwide. Biopharma alone held over $1.4

Biopharma 98

Biopharma Specialization Leads Competition 98

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 98

Medicine Healthcare Healthcare Manufacturing 98

European Pharmaceutical Review

NOVEMBER 3, 2022

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Germany (in second place) and the UK achieved double-digit growth.

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

European Pharmaceutical Review

OCTOBER 5, 2022

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 104

Pharma Training Networking Pharmaceutical 104

PM360

NOVEMBER 12, 2023

Amateur night is known for attracting performers from around the world and intense audience engagement, whereby favorite acts move forward in the competition and others are booed. Kofi Boakye took home the $20,000 Grand Prize in 2022. The Finale is a remarkable show! The acts are top talent from around the U.S.

Competition 98

Competition 98

European Pharmaceutical Review

OCTOBER 18, 2022

Examples of this include certain clinical developments, which can benefit from competition between pharmaceutical firms. Trends in biopharma contract manufacturing 2022. . Economic analysis predicts positive returns to those that provide R&D services when economies of scope across projects and technological spillovers are limited.

Biopharma 98

Biopharma Competition Pharmaceutical Marketing 98

pharmaphorum

JULY 14, 2022

The two companies said the transaction is expected to close by the end of 2022, subject to approval by the competition authorities.

Competition 97

Competition Pharma Sales Medicine 97

Celeritas

NOVEMBER 7, 2022

The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. The post The Value of Precision Livestock Farming (PLF) in 2022 appeared first on Celeritas | Digital Consulting. Effort Expectancy. This regards the perceived complexity involved in the operation of the system.

Networking 52

Networking Pharmaceutical products Management Transportation 52

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Read on to for insights from our analysts on: Global highlights from ESMO 2022. Key ESMO 2022 highlights from Mainland China. Seven global highlights from ESMO 2022.

Marketing 52

Marketing Safety Patients Competition 52

European Pharmaceutical Review

OCTOBER 19, 2022

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” Cited 25 September 2022]. Cited 25 September 2022]. September 09, 2022.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

European Pharmaceutical Review

JULY 25, 2023

billion in 2022. Other molecule types Small molecule API manufacturers are in fierce competition with medicines such as biologics, the report stated. According to the report, higher competition has therefore increased demand. billion by 2032. This is a rise from $162.8 A compound annual growth rate (CAGR) growth of 5.9

Marketing 97

Marketing Manufacturing Competition Pharmaceutical 97

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. Competition from Retail and Telehealth Disruptors Continues to Intensif y. The COVID-19 pandemic supercharged a new type of competition for legacy healthcare organizations.

Healthcare 109

Healthcare Healthcare Marketing Competition 109